ARYx Therapeutics, Inc. — Form D
ARYx Therapeutics, Inc. of FREMONT, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-08-30. The offering totals $5.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-08-30
- Form: D
- Accession: 0001410064-10-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $5.0M
- Amount sold: $2.0M
- Remaining: $3.0M
- Investors: 7
- Date of first sale: 2010-08-13
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-147064
Issuer
- Name: ARYx Therapeutics, Inc.
- CIK: 0001410064
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 6300 DUMBARTON CIRCLE, FREMONT, CA, 94555
- Phone: (510) 585-2200
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| David Beier | Director | Fremont, CA |
| Lars Ekman | Director | San Diego, CA |
| Paul Goddard | Director | San Francisco, CA |
| Keith Leonard | Director | Calabasas, CA |
| Hermn Rosenman | Director | Fremont, CA |
| Paul Sekhri | Director | New York, NY |
| Nick Simon | Director | South San Francisco, CA |
| Pascal Druzgala | Executive Officer | Menlo Park, CA |
| Paul Goddard | Executive Officer | San Francisco, CA |
| David Nagler | Executive Officer | Fremont, CA |
| John Varian | Executive Officer | Fremont, CA |
| Paul G Sekhri | Director | Boston, MA |
| Lars G Ekman | Director | Palo Alto, CA |
| Peter G Milner | Director | Ft. Thomas, KY |
| Peter G Milner | Executive Officer | Ft. Thomas, KY |
| Nick G Simon | Director | Fremont, CA |
| Herm G Rosenman | Director | Fremont, CA |
| David G Beier | Director | Fremont, CA |
| Pascal G Druzgala | Executive Officer | Fremont, CA |
| Daniel G Canafax | Executive Officer | Fremont, CA |
| David G Nagler | Executive Officer | Fremont, CA |
| Keith G Leonard | Director | Fremont, CA |
| John G Varian | Executive Officer | Fremont, CA |
Other filings by this issuer (1)
More